Beam Therapeutics (NASDAQ:BEAM) reported its Q1 earnings results on Wednesday, May 10, 2023 at 06:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Beam Therapeutics beat estimated earnings by 0.75%, reporting an EPS of $-1.33 versus an estimate of $-1.34.
Revenue was up $15.78 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.79 which was followed by a 4.32% drop in the share price the next day.
Here’s a look at Beam Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.33 | -1.31 | -1.08 | -1.32 |
| EPS Actual | -0.54 | -1.56 | -1.02 | -1.01 |
| Revenue Estimate | 12.53M | 7.94M | 8.39M | 5.91M |
| Revenue Actual | 20.04M | 15.80M | 16.65M | 8.43M |
To track all earnings releases for Beam Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
